Trial Profile
Treatment persistance with vedolizumab in patients with Crohn's disease and ulcerative colitis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Jan 2017
Price :
$35
*
At a glance
- Drugs Vedolizumab (Primary)
- Indications Crohn's disease; Ulcerative colitis
- Focus Therapeutic Use
- 09 Jan 2017 New trial record